BelFIBRO®

Hepatic rapid test kit

With the lateral-flow test BelFIBRO, which is to be supplied with serum, you have the possibility in your practice to determine the liver status of your patients reliably and non-invasively on site without risk for screening examinations or also as a specific diagnostic agent for liver diseases that have already been diagnosed. The various liver stages from fatty liver to cirrhosis can be diagnosed with a reliability of approx. 94%.

With the lateral flow test, practicing physicians get a wide diagnostic window that is covered by only one test. Only a few minutes of testing time are necessary to significantly increase the diagnostic window and the patient’s chances of survival.

For more informations PHARMACT.asia

Description

Risk factors for liver diseases are heavy alcohol consumption, chronic infectious hepatitis, fatty liver (hepatic steatosis), male sex, impaired immune system (HIV, immunosuppressive drugs), insulin resistance (ß-cell dysfunction, increased intact proinsulin), age over 50 years.

The IVD biomarker correlates linearly with liver development from healthy organ (F0, ≤54 ng/ml) via fatty liver (F1, 54-79 ng/ml) and liver fibrosis (F2, F3, 80-134 ng/ml) to irreversible liver cirrhosis (≥135 ng/ml).

The test shows a qualitative result starting at level F2 and above. The quantitative values can be determined immediately in the field using a scanning device.

BelFIBRO®

Related products

Login